GMAB financials
Genmab (GMAB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
GMAB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $3.72B | $3.41B | $1.25B | $963.76M | 1.54 |
| 2024 | $21.53B | $20.54B | $6.70B | $7.84B | 12.14 |
| 2023 | $16.47B | $16.25B | $5.32B | $4.35B | 6.60 |
| 2022 | $14.51B | $14.51B | $6.27B | $5.45B | 8.26 |
| 2021 | $8.42B | $8.42B | $2.95B | $2.96B | 4.48 |
| 2020 | $10.11B | $10.11B | $6.31B | $4.76B | 7.22 |
- GMAB revenue was $3.72B in fiscal 2025, net income $963.76M.
Updated 2026-11-02 18:32 UTC